Is INO or INTS more undervalued in 2026?

CirclFi compares Inovio Pharmaceuticals, Inc. (INO) and Intensity Therapeutics, Inc. (INTS) using 13 institutional-grade valuation models. INO has a Quality of Company score of 4.3/10 while INTS scores 3.7/10.

Which is a better buy — INO or INTS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INO and INTS valuations compare?

INO at $1.30 and INTS at $4.42 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INO vs INTS Valuation Comparison 2026 — Intrinsic Value Analysis

INO

Biotechnology

Inovio Pharmaceuticals, Inc.

Quality

4.3

out of 10

Value Trap

WARN

Price

$1.30

Last close

Models

8/13

Active

INTS

Biotechnology

Intensity Therapeutics, Inc.

Quality

3.7

out of 10

Value Trap

SAFE

Price

$4.42

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	INO Fair Value	INO Upside	INTS Fair Value	INTS Upside
Bayesian DCF	Intrinsic	$0.48	-63.1%	$3.24	-26.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.39	+7.0%	$0.26	-95.1%
Dynamic NAV	Asset-Based	$2.08	+60.0%	$8.03	+81.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INO vs INTS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INO vs INTS — Which Stock Is More Undervalued?

INO scores higher with a 4.3/10 quality rating vs INTS's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Inovio Pharmaceuticals, Inc. (INO) and Intensity Therapeutics, Inc. (INTS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INO currently trades at $1.30 with a QOC of 4.3/10, while INTS trades at $4.42 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).